INTRODUCTION
Patrinia villosa (Thunb.) Juss (Valerianaceae), an herbaceous plant, is distributed mainly in East Asia and Northeast North America. It is a commonly used herbal medicine in China for treatment of carbuncles, acute appendicitis, hepatitis, amygdalitis, angina parotidea, anthracia, stasis, intestinal abscess, postpartum pain, dysmenorrhoea and endometriosis for hundreds of years. Little biological activity of P. villosa constituents was evaluated, although P. villosa was reported to be a rich source of flavonoids (Peng et al., 2006a (Peng et al., , 2005a (Peng et al., , 2006c (Peng et al., , d, 2005c . The proangiogenic activity of the extract of P. villosa is confirmed by an in vitro mouse aortic ring assay and an in vivo murine hindlimb ischemia model (Jeon et al., 2010) . Yang et al. (2006) showed that the whole extracts of P. villosa extract improved myocardial and cerebral oxygen consumption. Moreover, saponin extract from P. villosa effectively reduced the weight of U14 cervical tumor, inhibited proliferating cell nuclear antigen (PCNA) of tumor cell, decreased the expression of mutant p53 and bcl-2 protein (Zhang et al., 2008) . However, little is known about a systematic comparison of antitumor effects on different cell lines between the total saponin extract from P. villosa (SPV) and the total flavonoid extract from P. villosa (FPV) and the signaling mechanisms responsible for their biological activity. Therefore, in this study, the antitumor effects and the possible mechanisms of SPV and FPV were investigated in four cancer cell lines including mouse melanoma cell line B16, MCF-7 human breast cancer cells, Hela human epithelial cervical cancer cells and L1210 mouse lymphocytic leukemia cells.
MATERIALS AND METHODS

Chemicals and reagents
Cell culture media, phosphate buffer solution (PBS) and fetal bovine serum (FBS) were from Gibco (Tulsa, OK, USA). All cell culture plastic ware (COSTAR®) was purchased from Corning (New York, USA). 3-(4,5-Dimethyithiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was from Promega Corporation (WI, USA). The Via Count Assay kit, the Guava Cell Cycle kit and enhanced chemiluminescence detection kit were from Millipore (Millipore Corporation, Hayward, CA). Antibodies for CDK4 (sc-200) , cyclin D1 (sc-575) and secondary antibodies were obtained from Santa Cruz Biotechnology Inc. (CA, USA). Macroporous resin D101 was purchased from the Chemical Plant of NanKai University (Tianjin, China).
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Extraction of SPV
Dried P. villosa rhizomes were pulverized and extracted with 95% ethanol. The solvent of the extract solution was evaporated under vacuum. The dried extract was dissolved in water, and then extracted with petroleum ether. The water phase was absorbed by macroreticular resin D101. The SPV was eluted with 75% ethanol aqueous solution, followed by lyophilizing to give the extract (Xu et al., 2006) .
Extraction of FPV
Dried P. villosa rhizomes were pulverized and extracted with 75% ethanol by Suoshi extraction method and the flavonoids content was measured using ultraviolet (UV) spectrum (Xu et al., 2004) .
Cell lines
The mouse melanoma cell line B16, MCF-7 human breast cancer cells and Hela human epithelial cervical cancer cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 2 mM L-glutamine and 10% foetal calf serum. L1210 mouse lymphocytic leukemia cells were cultured in RPMI 1640 media supplemented with 2 mM L-glutamine and 10% foetal calf serum. All cells were cultured in media supplemented with 1% penicillin/streptomycin and kept at 37°C and humidified in 5% CO2.
Growth inhibition analysis
SPV and FPV were dissolved in dimethyl sulfoxide (DMSO). Cells were seeded in 6-well plates. After 1 day, various concentrations of extracts were added to the wells. The final concentration of DMSO was 0.5%. Controls were exposed to culture medium containing 0.5% DMSO without drugs. Cell proliferation was evaluated using an MTT assay. The dark blue formazan crystals formed in intact cells were solubilized with DMSO, and optical densities at 570 nm was measured with a TECAN infinite M200 (TECAN Group Ltd).
Cell proliferation analysis
Cells were routinely seeded into 6-well plates at 2×10 4 cells/well and incubated at 37°С for 24 h. Cells were incubated with various concentrations of extracts for 48 h. At the end of this time, the cells were trypsinized to produce a single cell suspension, and the viable cell number in each well was counted using the Via Count Assay (Guava Technologies, Hayward, CA).
Cell cycle analysis
Cells were trypsinized, centrifuged, and fixed in ice-cold 70% ethanol at 4°C for 16 to 24 h. Evaluation of cell cycle was carried out using the Guava Cell Cycle Kit. Cell pellets were resuspended in 200 µl Guava Cell Cycle Reagent for 30 min at room temperature, shielded from light. The stained cells were analyzed using the Guava EasyCyte™MINI (Guava Technologies, Hayward, CA) and data were analyzed using the Guava CytoSoft software package.
Western blot analysis
For Western blot analysis, 30 µg samples of cell extract were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted. The following primary antibodies were used: rabbit polyclonal antibodies to CDK4 (sc-200), cyclin D1 (sc-575) at 1:5000 dilutions for 2 h. The antigenantibody complex was then detected by incubating the membrane for another 1 h in buffer containing a 1:5000 dilution of horseradish peroxidase-conjugated anti-rabbit immunoglobin G (IgG) secondary antibody. Excess antibody was washed off with 20 mM TBST (20 mM Tris, 150 mM NaCl, pH 7.5, and 0.1% Tween 20). Detection was performed using enhanced chemiluminescence detection kit. Band intensities were quantified with the software of quantity one.
Statistical analysis
Results are given as means ± standard deviation (SD). Student's two-tailed t-test or one-way analysis of variance was used to determine significant differences between two means (P<0.05 or P<0.01).
RESULTS
Antiproliferative effects of SPV and FPV on different cancer cell lines
The cell growth inhibitory effects of SPV and FPV on four cancer cell lines were determined using the MTT assay. As shown in Figure 1A , compared with SPV, FPV showed much stronger antiproliferative effects on L1210 cells in a dose-dependent manner (P<0.01). On the other hand, SPV showed better antiproliferative effects than FPV on the other three cell lines in a dose-dependent manner (P<0.01), including Hela, MCF-7 and B16 cells ( Figure 1B) . The most potent antiproliferative effects were observed on Hela cells treated with SPV and L1210 cell lines treated with FPV. At 0.1 mg/ml for 48 h, the FPV inhibited cell growth by 72.1% in the L1210 cell line, and SPV by 59.5% in the Hela cells, respectively. The results of flow cytometry analysis showed the same trend as with MTT assay. As shown in Figure 2 , the percentage of dead cells increased significantly after 48 h of treatment, and the inhibition rates of the cell proliferation were similar with MTT assay results for both extracts.
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Effects of SPV and FPV on cell cycle
To explore the potential mechanism of SPV and FPV inhibited cell growth, the cell cycle profile was assayed by flow cytometry after staining with propidium iodide (PI). Based on the MTT and ViaCount assay data, the effect of SPV on Hela, MCF-7, and B16 cells cycle and of FPV on L1210 cells cycle were evaluated. As shown in Table 1 , the S-phase population of four different cell lines significantly decreased in dosedependent manners (P<0.01). Compared with the control, cell cycle profile was changed after 48 h treatment. FPV treatment obviously decreased S-phase cells of L1210 cells at 0.02 and 0.05 mg/ml. However, the 0.05 and 0.1 mg/ml of SPV decreased S-phase cells of other three cell lines.
Effects of SPV and FPV on expression of CDK4 and cyclin D1
It was reported that cyclin D1 and its catalytic partner CDK4 played important roles in the G1/S checkpoint of the cell cycle. To observe additional information involved in the cell cycle regulations, the expression of cyclin D1 in Hela, MCF-7, B16 and L1210 cancer cells was evaluated (Figure 3) . FPV down-regulated the expressions of cyclin D1 and CDK4 in a dose-dependent manner in L1210 cells. In the same way, SPV down-regulated the expressions of the two proteins in a dose-dependent manner in Hela, MCF-7 and B16 cells. As shown in Figure 3B compared to the control, the incubation in Hela cells with 0.05 and 0.1 mg/ml SPV for 48 h, resulted in decreased of CDK4 to 39.6 and 19.5% and cyclin D1 also decreased to 13.2 and 8.1%, respectively. In L1210 cells, incubation with 0.03 and 0.05 mg/ml FPV for 48 h, resulted in decreased of CDK4 to 59.7 and 22.0% and cyclin D1 also decreased to 49.0 and 21.1%, respectively.
DISCUSSION
P. villosa is used to treat bowel cancer and carcinoma of the bladder. However, there are no report about a systematic comparison of antitumor effects on different cell lines between SPV and FPV, although many of the components have been separated (Peng et al., 2006a (Peng et al., , b, 2005a and antitumor effects of SPV on mice bearing U14 cervical cancer had been researched (Zhang et al., 2008) .
In this study, we compared the antiproliferative potential of SPV and FPV using four cancer cell lines. The cancer cell lines used includes four types of cancers, mouse melanoma cell line B16, MCF-7 human breast cancer cells, Hela human epithelial cervical cancer cells and L1210 mouse lymphocytic leukemia cells. The results of MTT assay showed that the FPV inhibited the To further elucidate the mechanism of antiproliferative effects of FPV and SPV on malignancies, other methods for detection were used. A number of investigators observe that the G0/G1 cell cycle arrest and/or the Sphase fraction decrease correlated well with apoptosis (Massague, 2004) . Our data confirmed that the cells treated with the P. villosa extracts, both FPV and SPV, exhibited statistically significant block of G0/G1 or G2/M phases, and obviously decrease the S-phase fraction (Table 1) . Since cyclins and cyclin-dependent kinases regulate cell cycle progression, the expression of cyclin D1 and CDK4 in cancer cells were determined.
Cellular proliferation follows an orderly progression through the cell cycle, which is regulated by protein complexes that composed of cyclins and cyclindependent kinases. Cyclins are a family of cell cycle control proteins that regulate cell cycle progression by associating with and activating CDKs (Besson et al., 2008; Musgrove et al., 2011) . The deregulated expression of G1 or G1/S phase cyclins or their related CDKs may cause loss of cell cycle control and thereby contribute to neoplastic transformation, because the major regulatory events leading to mammalian cell proliferation and differentiation occur in the G0 to G1 phases or in the G1 to S phase transition during the cell cycle (Harbour et al., 1999; Hartwell et al., 1994; Hunter et al., 1994) . The Kaplan-Meier analysis show that cyclin D1 and CDK4 over expression are significantly associated with disease-free survival and overall survival, and these proteins over expression may play a pivotal role in the biological behavior of malignancies and may provide a strong prognostic implication (Dong et al., 2001) . The results showed that SPV and FPV have similar effects in decreasing the protein expression of cyclin D1 and CDK4 protein. These results showed that SPV and FPV might inhibit cyclin D1 and CDK4 protein expression to inhibit tumor growth.
Conclusively, pharmacological data obtained from this study suggested that FPV and SPV possessed cancer chemopreventive potential on different types of cancer cells. The mechanisms involved in cancer chemoprevention by FPV and SPV extracts were cell cycle arrest and induction of apoptosis. A bioactivity-guided approach based on different type of cell lines growth inhibition will be taken to identify the active compounds in FPV and SPV.
